CalAIM 1115 演示评估
返回 CalAIM 1115 示范 和 1915b 豁免主页
As required by the CalAIM 1115 Demonstration’s Special Terms and Conditions, the State must submit evaluation reports to the Centers for Medicare and Medicaid Services (CMS) to determine and analyze the impacts of several demonstration programs over the course of the demonstration period. If you have any questions or concerns, please contact 1115Waiver@dhcs.ca.gov.
On June 27, 2022, DHCS submitted the Draft Evaluation Design for Providing Access and Transforming Health (PATH) Initiative, Global Payment Program (GPP), and Dually Eligible Beneficiary Satisfaction in the Medi-Cal Matching Process.
On December 5, 2022, DHCS received CMS comments on the Draft Evaluation Design. The due date for the PATH/GPP/Duals Evaluation Design has been formally extended by CMS to January 25, 2024.
2 月,,7 2024DHCS 提交了一份经修订的 评估设计草案 和 信件，其中包含对 CMS 125 月,2022 关于 PATH/GPP/Duals 和 Reentry Demonstration 问题的回复 。
4,2025, DHCS 于 8 月提交了修订后的《社区支持评估设计》。
2 月28 ，2025 ，DHCS 提交了经修订的 PATH、GPP、Duals、Reentry 和管理性保健计划示范的评估设计草案 ，以及 DHCS 和评估小组对 CMS 6 月5 ，2024 意见的答复 。
72025,, DHCS 收到了 CMS 对 CS、PATH、GPP、Duals、Reentry 和 Managed Care Plans 示范项目评估设计的 批准 。
29,2025, DHCS 于 12 月向 CMS 提交了以下 CalAIM 临时评估报告文件草案：
COVID-19 Public Health Emergency – Managed Care Risk Mitigation Strategies
药物 Medi-Cal 有序配送系统 (DMC-ODS)
Additional information about the DMC-ODS Evaluation is available on the UCLA ISAP webpage.